{
    "pmid": "41410255",
    "title": "Hepatocellular carcinoma in non-cirrhotic liver: a prospective Spanish multicenter study.",
    "abstract": "Prospective data on non-cirrhotic hepatocellular carcinoma (NC-HCC) are scarce, mainly in Western countries. Characteristics, evolution, prognostic factors and outcomes were analyzed. One hundred and forty-one NC-HCC diagnosed by histology were included in a Spanish multicenter prospective registry (2018-2023) involving 23 centers. Liver cirrhosis was excluded by histology, transient elastography or level 2 Mittal criteria. Underlying chronic liver disease was present in 77% of patients, mainly MASLD/MetALD and viral. Using the aMAP risk score less than 10% of patients were classified in the low-risk group. Fibrosis stage was 0-1 in 53%. A single nodule was detected in 75%. The BCLC stage was 0 in 6.5%, A in 63.8%, B in 17.7%, C in 11.3% and D in 0.7%. Initial treatment was surgical resection in 63.9%, ablation in 4.2%, TACE/TARE in 13.5%, systemic therapy in 14.9%, and symptomatic treatment in 3.5%. Median follow-up was 34.1 (IQR: 15.5-49.5) months. Median overall survival was 47.9 months (95% CI: not assessable), and global 1-, 3- and 5-year survival rate were 85%, 62.4% and 49.1%, respectively. AFP level (<20/â‰¥20ng/ml) [HR: 2.63 (1.3-5.3), p=0.007] was an independent predictor of survival. In surgically treated patients, the 5-year recurrence rate and 5-year survival rate were 55.1% and 59.1%, respectively. Active lifestyle (HR 0.27 [95% CI: 0.09-0.8]) and microvascular invasion and/or satellite nodules (HR 3.03 [95% CI: 1.18-7.75]) were independent predictors of mortality. Despite the lack of routine screening, most patients with NC-HCC were diagnosed at early stages and treated with surgery. The main underlying etiology was MASLD/MetALD and a sedentary lifestyle was associated with mortality, so interventions to improve this aspect are essential.",
    "disease": "liver cirrhosis",
    "clean_text": "hepatocellular carcinoma in non cirrhotic liver a prospective spanish multicenter study prospective data on non cirrhotic hepatocellular carcinoma nc hcc are scarce mainly in western countries characteristics evolution prognostic factors and outcomes were analyzed one hundred and forty one nc hcc diagnosed by histology were included in a spanish multicenter prospective registry involving centers liver cirrhosis was excluded by histology transient elastography or level mittal criteria underlying chronic liver disease was present in of patients mainly masld metald and viral using the amap risk score less than of patients were classified in the low risk group fibrosis stage was in a single nodule was detected in the bclc stage was in a in b in c in and d in initial treatment was surgical resection in ablation in tace tare in systemic therapy in and symptomatic treatment in median follow up was iqr months median overall survival was months ci not assessable and global and year survival rate were and respectively afp level ng ml hr p was an independent predictor of survival in surgically treated patients the year recurrence rate and year survival rate were and respectively active lifestyle hr ci and microvascular invasion and or satellite nodules hr ci were independent predictors of mortality despite the lack of routine screening most patients with nc hcc were diagnosed at early stages and treated with surgery the main underlying etiology was masld metald and a sedentary lifestyle was associated with mortality so interventions to improve this aspect are essential"
}